Ningxia Zhongke Biotechnology Co (600165) Fair Value & Analysis
Basic Materials · CN · Market cap 4.6B CNY
Analysis
Ningxia Zhongke Biotechnology Co (600165) currently trades at ¥2.73, while our model-based Fair Value estimate is ¥2.24 — implying the stock looks roughly 17.9% overvalued today. We read business quality at 87/100 (high quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).
About the company
Ningxia Zhongke Biotechnology Co., Ltd. produces and sells coal-based activated carbon and lauric acid products. The company was founded in 1958 and is based in Shizuishan, China.
Open the full interactive analysis →
Similar stocks
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.